• FuelPositive CEO Ian Clifford was featured in a recent Stock2Me Podcast episode
• Clifford noted that the company is at the forefront of developing the dialog around adaptable carbon-free NH3 and is taking a thought leadership stance in that space
• In April 2021, FuelPositive purchased a cutting-edge technology designed to produce carbon-free ammonia in a scalable, modular, and economically viable fashion
• The company is currently manufacturing the demonstration units for this patent-pending technology and is planning demonstration programs aimed at showcasing the technology’s real-life applications initially in the agriculture sector
• FuelPositive is also targeting the transportation sector as well as hydrogen storage

Toronto-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is looking to change the energy landscape through its flagship project, which entails using its proprietary, first-of-its-kind technology to produce carbon-free ammonia (“NH3”) in a scalable, modular, environmentally sound, and economically viable fashion. NHHHF is targeting three primary segments – agriculture, transportation, and energy storage – all in an effort to significantly reduce carbon dioxide (“CO2”) emissions from human activities, so far, the single largest contributor to global warming. According to FuelPositive CEO Ian Clifford, who was speaking in a recent Stock2Me Podcast episode hosted by Stuart Smith, the company purchased this cutting-edge technology, whose use will herald a departure from how NH3 is currently synthesized, in April this year (https://ibn.fm/dWjjL). Today, the industrial synthesis of NH3 through the Haber-Bosch process is one of the most “carbon-intense processes on the planet” – producing one ton of NH3 emits about 2 tons of CO2, translating to 1.44% of total Co2 emissions globally. In addition, the process is energy-intensive, using up 1-2% of the world’s total energy production (https://ibn.fm/T9qCE). Clifford observed that these disadvantages have historically meant that NH3 could not be recognized as a viable fossil fuel replacement, but the company’s technology is looking to change that narrative. “Our system is entirely carbon-free,” said Clifford. “We take sustainable electricity, water, and air, and we produce carbon-free NH3, which can be utilized across multiple industries as an extremely versatile material… We are now just in the process of commercializing the technology, and we plan to have demonstration units ready and out there in the real world early in 2022.” The demonstration units, currently in the manufacturing stage with National Compressed Air in Toronto, will enable FuelPositive to showcase real-world applications for the technology. To this end, the company is focused on determining and putting in place the best, highest-profile demonstration programs possible early in 2022. It is working with the Sussex Group, a government relations group based in Ottawa and Toronto, to ensure it has the best and highest visibility for the demonstration programs. FuelPositive will initially focus these demonstration programs on agriculture, as the sector already understands the importance of NH3 as a fertilizer – about 80% of the NH3 produced is used as fertilizer, either for direct application or conversion into nitrogen fertilizer. “Our demonstration projects initially in agriculture would see a farm that utilizes NH3 today having a FuelPositive system installed on the farm, utilizing sustainable electricity… and producing all of the NH3 they need for fertilizer requirements for their farm,” Clifford continued. “Add to that this incredible versatility of NH3, that the NH3 molecule is more than just a fertilizer – it’s a fossil fuel replacement fuel, it’s a very effective refrigerant, and it’s a very important chemical in a lot of other processes.” According to Clifford, the farm can use the onsite technology to produce carbon-free NH3 (1) for its fertilizer needs, (2) to power its tractors and combine harvesters, and (3) as a propane replacement in the crop-drying systems. FuelPositive’s technology will also substantially benefit farmers by helping them decarbonize as well as reduce their reliance on existing fertilizer and fossil fuels supply chains, which increase their vulnerability to erratic price changes. Additionally, being modular and scalable, the technology is ideal for both large and small farms. With a focus on the transportation sector, which in 2019 accounted for 24% of the direct C02 emissions from fuel combustion globally (https://ibn.fm/YZdhS), FuelPositive is targeting pure carbon-free transportation solutions. It aims to achieve this by replacing fossil fuel products – gasoline and diesel – with carbon-free NH3 in converted internal combustion engines. Notably, upon proper combustion, carbon-free NH3 only emits steam/water vapor. FuelPositive also intends to use carbon-free NH3 as the perfect carrier for hydrogen (“H2”) in the hydrogen economy, given that NH3 is the most hydrogen-dense material on the planet and is easier to store than H2. “When you start looking at the viability of H2 fuel cells and H2 combustion down the road, the real answer to the via this is carbon-free NH3,” Clifford explained. “Green NH3 is an enabler for the hydrogen economy. So, there is a very significant role for NH3 in the future of hydrogen.” To listen to the whole podcast, please visit https://ibn.fm/8Ssc8 For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• A 2020 Deloitte China report noted that big data will be vital in ensuring insurance survive for longer post-pandemic and accelerate their transformation towards excellence
• Big data is instrumental in facilitating greater product innovation and pricing accuracy for insurers
• Through its Big Data Insights division (Sapientus), FingerMotion appears well positioned as an ideal partner for insurers looking to implement Deloitte’s proposals
• The China Banking and Insurance Regulatory Commission recently scrapped the 51% cap on foreign ownership, setting the stage for potential growth of the country’s insurance sector

Last year, Deloitte China released a report titled “COVID-19 and China’s Insurance Industry” that explored the measures insurers have taken to deal with the pandemic, the macro impact of COVID-19 on the insurance industry, and, lastly, how insurance companies should accelerate their transformation towards excellence (https://ibn.fm/U2kpn). The report noted that big data, which some insurers were already using as early as February 2020, will be instrumental in the post-pandemic insurance world. According to Deloitte China, the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams. This means that these firms need to consider building sustainable management systems to ensure longevity moving forward. The report proposed that insurers should apply big data to facilitate product differentiation and build digital operational capabilities. With mechanisms already in place, having launched its Big Data Insights division (Sapientus) in July 2020 and subsequently partnered with Pacific Life Re-Insurance, evolving technology company FingerMotion (OTCQX: FNGR) appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. Speaking in an August 25 corporate update, FingerMotion CEO Martin Shen noted that Sapientus stands out because of its ability to integrate publicly available data into proprietary risk matrices with behavioral indicators derived from event-driven or contextual-based information. Through the provision of behavioral analytics, FNGR is looking to supply actionable intelligence and enable efficient service delivery to potential clients within the insurance industry (https://ibn.fm/I1Nhu). Incidentally, the Deloitte report had alluded to this particular application of big data. It recommended that insurers should make full use of data from external and internal sources to “facilitate quantitative models for customer segmentation, and thus more accurate pricing and greater product innovation.” FingerMotion’s efforts in the insurance sector coincide with a recent move by the China Banking and Insurance Regulatory Commission (“CBIRC”) to scrap the 51% cap on foreign ownership in insurance businesses in a bid to open up the domestic insurance market and expand the sector (https://ibn.fm/WJ936). In its analysis, Mordor Intelligence quoted the resultant potential increase in the number of insurance companies in China due to CBIRC’s move as one of the factors expected to help the sector grow even further. The market research company projects that China’s life and non-life insurance market will grow at a 6% CAGR from 2020 to 2025 (https://ibn.fm/jCqxM). At the same time, the online insurance market is expected to grow at a 41% CAGR from 2019 through 2024 (https://ibn.fm/9O90d). FingerMotion is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. It is also targeting the burgeoning rich communication services (“RCS”) segment, with the expectation that RCS will form the company’s fourth division once launched. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

ACP created a cash flow positive model that protects shareholders Privately owned American Cannabis Partners (“‘ACP”), a multistate operator creating a sustainable Jamaican cannabis experience, has created a cash flow positive business model that protects shareholders and the company regardless of the fluctuations in the industry. ACP’s CEO, Stephen Jordan worked in the cannabis business for three years in Jamaica. He brought those relationships, and employees with 30-40 years of experience in cultivation, back with him to California when recreational cannabis became legal in 2018. The company currently operates in Northern California and Michigan with plans to expand into a third state within the next year. Tangible assets like real estate and equipment play a key role in creating stability for ACP before building the company out. They have acquired 11 cultivation licenses, one retail license, and have around 560,000 square feet of canopy space for cultivation. This provides the safety net to liquidate if necessary to stay in business while also protecting shareholders. ACP will remain cash flow positive as they move forward into their projected third U.S. state in 2022 and a fourth in 2024. Assets and safety are essential values to the company, and, says Jordan, “That’s one of the hardest things to find in this industry. A lot of people and a lot of companies have products, but they’ve placed themselves in very strenuous liability situations. If they can’t make a product, they no longer have a company. ACP took the opposite direction” (https://ibn.fm/S0VV8). The company’s “asset and safety strategy” is to acquire real estate and licenses in states that have newly passed cannabis legalization. This allows them to capitalize on Federal interstate commerce opportunities. Additional strategies are in place to capture the growth of emerging medical and recreational commercial markets. Concern for the shareholder’s safety highlights the company’s overall care for others. A recent article shares what ACP refers to as its triple bottom line and goal to positively impact people (as a high-paying grower), the planet (100% organic material), and profits (through assets and safety) (https://ibn.fm/iMcpx). The people will always come first. This is seen most clearly in ACP’s continued commitment to the needs of Jamaica and its people. In addition to cultivation and real estate, ACP is focused on medical research. The company’s newly added medical director, Jeereddi A. Prasad, M.D., is responsible for placing physicians of various specialties in direct interaction with cultivators, to genetically steer plants for volunteer clinical research studies that focus on PTSD, Parkinson’s, and other conditions. This is a company worth watching as they continue to spread out across the U.S., maintain the status as a high-paying grower, while remaining environmentally friendly and cash positive. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

• Flora Growth Corp., a cannabis company with low-cost cultivation and global distribution, recently reached a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply product from its portfolio
• Panama is a country on the verge of opening to medical marijuana sales and the first in Central America to open a regulated market following legislation approved without a dissenting vote by the National Assembly
• Flora Growth maintains a large licensed outdoor operation in Colombia, from which it cultivates cannabis that will be used in a variety of branded products
• Flora Growth has been increasing its international outlets, including an agreement with Hoshi International Inc. expected to open up numerous opportunities in the European Union

On the heels of news that Panama’s National Assembly congress passed legislation legalizing medical marijuana (https://ibn.fm/gfh8W), internationally focused cannabis cultivator and brand builder Flora Growth (NASDAQ: FLGC) is generating excitement through the establishment of a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply its premium cannabidiol (“CBD”)-derivative products. Panamanian President Laurentino Cortizo is expected to sign the legislation despite a veto campaign from the conservative political opposition, which will make Panama the first Central American nation to regulate the leafy green plant following decades of drug war rhetoric against cannabis and its marijuana product (https://ibn.fm/QOueo). Flora Growth will provide Panama’s Robust Farms with cannabinoid-containing food and beverages through its Kasa Wholefoods division, according to the company, once Robust’s cannabis import licensed is approved. Flora will also provide finished medical-grade cannabis products for patients under the expected regulatory framework. “We’re extremely pleased to enter into this agreement with Flora in order to pre-emptively secure access to their medical-grade cannabis products — which we believe is the first of its kind to be announced since the cannabis legislation passed — and look forward to supplying our clients with Flora’s premium portfolio of CBD-infused and non-CBD food and beverage products in the short term,” Robust CEO Maurice Holmes Mendez stated in the news release about the LOI (https://ibn.fm/OALh6). “While the new proposed framework awaits signature from the President, our team is hard at work building out our traditional and medical cannabis sales channels in the LATAM region, which relies heavily on working with experienced business partners and healthcare practitioners,” Mendez added. Flora Growth is headquartered in Canada, with its sights on relocating offices to the United States and core product cultivation operations in Colombia. The company’s end user markets include Australia and various countries in Latin America, Europe and Asia, demonstrating its global reach. The company’s European expansion plans are being advanced through the recent closure of a €2 million investment in Hoshi International Inc. — a fully integrated cannabis company with strong experience in working in the European market (https://ibn.fm/p7az0). Germany, which leads the European cannabis market in terms of growth, completed an estimated €111 million in medical cannabis trade between January and September of last year, with flower sales making up about 48.6 percent of the market, according to the Hoshi investment announcement. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• • Nug Avenue has picked up more than 10,000 new unique members as of the end of June, significantly exceeding initial projections
  • Sugarmade has opened an escrow account for the purpose of acquiring property in California to be used for delivery hub
  • SGMD has taken steps toward making an offer on licenses for the state of Oregon
  A growing cannabis delivery service, new commercial licenses and expansion into Oregon were highlights of a recent update provided by Sugarmade (OTC: SGMD). The emerging leader in the vertically integrated California cannabis marketplace released an update for current and prospective shareholders containing details of these key milestones in the company’s strategic plan (https://ibn.fm/um1TT). “Sugarmade. . . is pleased to update current and prospective shareholders on the Company’s growing Nug Avenue operations, as well as further strides toward verticalizing its model through the acquisition of California cannabis licenses and potentially establishing commercial operations in the cannabis delivery market outside of the state of California,” the report stated. “We continue to make tangible strides toward a vertically integrated model,” noted Sugarmade CEO Jimmy Chan. “Our long-term strategic vision is to establish the capacity to control all aspects of production, supply, manufacturing, packaging, distribution and delivery — to become a true ‘farm-to-door’ cannabis company. This vision should provide for better unit economics, margin growth and gains in product quality and customer satisfaction. Organic brand growth, property acquisition, licensing and geographic expansion are all important steps toward achieving that vision for Sugarmade and its shareholders.” Regarding Nug Avenue, the report noted that the company had established its initial Nug Avenue cannabis delivery operation in March 2021. Since that official launch, the operation has grown substantially, picking up more than 10,000 new unique members as of the end of June, a number that significantly exceeded the company’s internal projections. “We will have more details on Nug Avenue performance soon, but we wanted to report our strong progress and let our shareholders know that we are quickly establishing a brand presence in the Los Angeles cannabis delivery market at our first location, which should carry over to help in establishing rapid customer growth in new locations as we expand,” noted Chan. As for commercializing new licenses, the update reported that Sugarmade has officially opened an escrow account for the purpose of acquiring property. The company plans to use the property for one of three new non-storefront California cannabis licenses it is in the process of acquiring. In June 2021, Sugarmade announced that it had signed a memorandum of understanding to obtain three non-storefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation, along with corresponding licenses from the California Bureau of Cannabis Control, which collectively provide the licensing foundation for the opening of three new Nug Avenue cannabis delivery hubs in the Los Angeles metro area. Finally, the update reported that the company has taken steps toward making an offer on licenses for the state of Oregon; purchase of property may or may not include a real estate purchase in the process. “This is a step toward potentially establishing cannabis delivery operations in Oregon,” the update stated. “The Oregon recreational cannabis market is one of the largest and fastest-growing in the country, with total sales expected to top $1 billion this year.” Sugarmade has reached out to local service providers to move this expansion process forward, with further details expected to be released soon. Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes NUG Avenue, CarryOutsupplies.com and SugarRush. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

Not often does a company gain entry to the billion-dollar club. However, technology and communications pioneer Tingo (OTCQB: IWBB) just did it – twice.  Shortly after going public in a deal valued at $3.7 billion, Tingo rang the billion-dollar bell a second time with its acceptance into IBN’s Billion Dollar Club. This powerful adjunct program created exclusively for IBN CORE Client Partners gives Tingo personal access to Oren Klaff, best-selling author and world-renowned expert on sales, revenue acceleration and high-stakes negotiations. Commenting on the recent billion-dollar bonanza, Dozy Mmobuosi, CEO and co-founder of Tingo, stated, “Going public is the next stage in our overarching strategy to build complete digital ecosystems that promote financial inclusion, deliver disruptive financial services, and expand international economic opportunities across the entire continent of Africa. With our proven success in Nigeria, we are already well on our way to becoming the continent’s leading Agri-Fintech player. Going public provides us greater global recognition and access to capital markets which will help expedite our process to becoming a driving force in the economic expansion of the continent. We chose IBN for Tingo’s corporate communications needs based on their history of successfully serving over 500 public companies and their unwavering commitment to clearly communicating our message and helping us achieve our objectives. We were thrilled to discover that we also could get exclusive access to Oren Klaff and his expertise as part of our services and fully expect to rapidly accelerate our revenues and growth with his guidance and tutelage.” Tingo has been on a 20-year journey to billion-dollar status. Mmobuosi created Tingo in 2001 with a vision to build an ecosystem to support the largely unbanked agricultural sector in Nigeria. Tingo designed first SMS mobile banking and payment platform in Nigeria which is still in use today. With hard work and vision, Tingo has evolved into a rapidly expanding group of Fintech, Agritech, mobile, technology companies. Tingo provides strategic direction and corporate support to its subsidiaries, which offer telecommunications services, smartphones, voice & data services (its Tingo Mobile PLC subsidiary has sold over 21 million mobile devices over the past 7 years) and Agritech solutions, enabling access to global commodities markets, extension services and fintech tools for millions of small farmers. With over $600 million in annual revenues and nearly 10 million subscribers, Tingo is Nigeria’s leading Agri-Fintech and device-as-a-service company. Tingo helps farmers acquire mobile phones through a unique leasing plan and connects them to mobile and data networks through its own virtual mobile network. Tingo’s digital platform provides market access for farmers and cooperatives to sell their produce at either wholesale or retail levels, achieving the best possible market price, and currently processes over 500,000 transactions a day. Tingo continues to innovate and expand services across the continent, recently launching a beta version of TingoPay, a B2B and B2C Fintech app that will provide financial services to users inside and outside of agriculture offering mobile wallets, payment processing and access to specialist lenders, insurers and pension products. Tingo also plans to roll out a blockchain-based solution that will deliver frictionless trade across borders in Africa. The company’s successful market-proven model gives Tingo the unique ability to deliver the same service model across all of Africa and transform the continent with its innovative fintech and agriculture value chain solutions powered through smartphone technology. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

• AnPac Bio’s clinical laboratories are located in the U.S. and China, with a total of 142 patents issued as of March 2021
• Cancer Differentiation Analysis (“CDA”) technology is AnPac Bio’s approach to early cancer detection and screening technology, with over 200,000 samples and cases to serve as a way of approaching cancer screening
• Company’s ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co. Ltd. has increased from 20% to 60%, following rigorous regulatory assessments and audits

With a focus on early cancer screening and detection, biotechnology company AnPac Bio-Medical Science (NASDAQ: ANPC) recently announced that its U.S. laboratory has received accreditation from the College of American Pathologists (“CAP”). The U.S. federal government recognizes the CAP Laboratory Accreditation Program as equivalent to or more stringent than the government’s inspection program for laboratories. The accreditation from CAP is considered the gold standard for laboratories of this nature (https://ibn.fm/05KFN). AnPac Bio has clinical laboratories in the U.S. and China, totaling 142 patents issued as of March 2021. The company’s approach for detecting cancer and precancerous diseases is called Cancer Differentiation Analysis (“CDA”) and uses biophysical properties found in the blood to discover changing micro-environments towards cancerous micro-environments before the tumors are even formed.  CDA technology uses an assessment of biophysical properties in the blood, and CDA platform combines CDA technology with other tests such as biomarkers.  CDA is also helpful in potentially predicting multiple cancer types, through a blood test, which is a highly competitive price point. AnPac Bio’s CDA is powered by a database completed with over 200,000 samples and cases to serve as a new way of approaching disease and cancer screening. The company is an early thought leader and developer of multi-cancer ideas and technology, having begun its patent applications and IP in 2010, with the initial cancer detection test offering being able to detect 16 types of cancer announced by 2014. In addition to its CAP accreditation in the U.S., AnPac Bio has increased its ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co., Ltd., as approved by the audit committee and board of directors. The ownership increase from 20% to 60% follows a required due diligence process of financial and legal audits, in addition to appraisals by a qualified appraiser (https://ibn.fm/ZDDAY). “AnPac Bio is excited to have completed this important step. We are able to successfully incorporate with AnPai’s wide diversity of customers and high revenue growth through this transaction,” Dr. Chris Yu, CEO and Chairman of AnPac Bio said, commenting on the ownership share acquisition. “In the future, we will achieve faster and greater progress and development in the diversity of customers and the professionalism of our services, as well as projected sustainable revenue growth through our greater share ownership. We hope that customers will benefit from AnPac Bio’s CDA technology.” AnPac Bio’s CDA technology addresses numerous goals, which include innovating the cancer screening industry, detecting early signs of cancer in the body, identifying up to 26 different types of cancers, providing multi-level/multi-parameter analysis, proving the efficacy of the CDA technology through the 200,000 samples, and using human blood for the means of identifying biophysical properties in conjunction with cancer occurrences. The technology has positioned AnPac Bio as a leader on the cancer detection and screening market, with the largest on-going multi-cancer follow-up study in the world, an expanding market expected to reach $249.6 billion by 2026, growing at a CAGR of 7% during the forecast period. The rising incidence of cancer is triggering a higher demand for available and effective screenings and testing necessary for monitoring disease progression and increasing preventative measures. For more information, visit the company’s website at www.AnPacBio.com. NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

European Medical Cannabis Conference

• Tue, Sep 21 at 9:00 AM-5:00 PM
• Hybrid Conference – Virtual and In-Person
• Physical Venue: Schützenstraße 73, 10117 Berlin, Germany

MSO Growth and Consolidation Cannabis Conference 

• Tue, Sep 21 at 9:00 AM-5:00 PM
• Virtual Conference only

The European Medical Cannabis Conference and the MSO Growth and Consolidation Conference, organized by The Cannabis Society, invites medical professionals, professors, distributors, and experts for its hybrid physical/online conference. The Cannabis Society, a division of the Tech Society, executes 50+ conferences in the USA, Canada, and Europe annually. This platform facilitates productive communication among founders, investors, traders, and service providers of the cannabis industry. The European Medical Cannabis Conference is being held in Berlin, Germany, where live participants can attend as well as cannabis participants from Europe, Latin America, North America, and all over the globe are invited to the live event on the online platform. The MSO Consolidation Cannabis Conference is held to connect MSOs (Multi-State Operators) with SSOs (Single-State Operators) and educate attendees about the MSO consolidation strategies and leverage its online platform to facilitate capital opportunities in the market. With the changing cannabis landscape, The European Medical & MSO Consolidation Cannabis Conference aims to offer valuable information and discuss the latest market trends of the growing cannabis ecosystem. The conferences offer a huge arena for joint venture collaborations and give attendees direct access to connect with worldwide cannabis industry leaders. The events include keynotes, discussions and workshops to offer knowledge and education about the latest trends in the cannabis ecosystem. The participants include an influential lineup of industry thinkers, medical professionals, and executives who have years of knowledge and experience in the related fields which they will share with the attendees of the conference. All in-person attendees have access to the virtual platform as well. Participants attending the physical conference can look for other participants online or in the lounge area before a live session, during session breaks, and after the live session ends. To know more details about:

• MSO Growth And Consolidation Conference, click https://ibn.fm/LiAwE
• European Medical & Cannabis Conference (Physical/Online), click https://ibn.fm/ulHEN

• Forum features inspiring people who, through adversity, grit and persistence, are forging a path to being the best version of themselves
• Jones lives by a personal mantra: When I wake up every morning, I have two goals: learn something and make the world a better place
• Emaginos is committed to creating a learning environment that is personal and that provides students with a foundation of basic skills

Emaginos Inc. president Allan Jones was the featured guest on “Optimal Self Conversations,” an inspirational forum hosted by three-sport professional athlete and productivity coach Jeremy Herider (https://ibn.fm/wvC9A). The forum is designed to be a valuable resource that features interviews with inspiring people who, through adversity, grit and persistence, are forging a path to being the best version of themselves. Emaginos Inc. is raising capital from the general investing public under provisions of Regulation A and is seeking $3 million to implement its proven, patent-pending K-12 education system and transform the nation’s educational system (please see website if interested in investing). During the interview, Jones discussed his background, including his Naval Academy education, as well as his experience and philosophy about education. He also shared his personal mantra: When I wake up every morning, I have two goals: learn something and make the world a better place. “Those were values that I learned from my parents,” Jones stated during the interview. “My dad was one of those guys who would give you the shirt off his back if you needed it. If we learn to take pleasure from making other people feel good, we’ll never be unhappy. “You don’t even have to be successful at it,” he continued. “Just the very act of trying is rewarding. It’s not a zero-sum game. You get as much as you give. It’s not like if I give it to you, I gave it up and don’t have it anymore. I gave it to you, and I got more.” Jones talked about his training as a mechanical engineer, including an invaluable principle that he has recognized as applicable throughout his life, even outside of his profession as an engineer. “One of the things about engineering that really everybody should learn is that everything is part of a system,” Jones continued. “Nothing happens in isolation. So, I always looked at everything with curiosity. I was wondering, ‘What made that happen? What conditions were required in order for it to occur? What would have made it happen differently?’ That’s just the way my head works, a curiosity engine. And you know what? Everybody’s head works that way. “Anywhere you go — at the grocery store, the mall, a ball game — you can observe little kids learning. They are learning machines,” Jones continued. “As they touch something, they’re learning what it feels like, what it smells like. They learn almost everything by doing. Confucius said, ‘I hear, and I forget. I see, and I remember. I do, and I understand.’” The philosophy undergirds the very foundation of Emaginos, a company that Jones is passionate about. The company is committed to creating a learning environment that is personal and that provides students with a foundation of basic skills; the Emaginos approach also includes competence in problem solving and application of knowledge to relevant real-life problems. While the company believes that America’s K-12 public schools are a national treasure but that the system is broken — and cannot be fixed. There is a solution, however. The game-changing Emaginos model uses existing facilities, teachers, and administers and can be implemented within existing budgets using existing proven best practices. The company begins its transformation of education by working with an initial school within a district; that school serves as a model for the transformation. The charter model implements the Emaginos Discovery Learning System (“DLS”), which outlines a systemic transformation from the current teacher-centered model to a K-12 public education system that fosters and supports a student’s desire to learn. After the model is successful in the charter school, the lessons learned in transforming the initial school are used to continue the change throughout the rest of the school district. Dedicated to transforming K-12 public schools to a model composed of integrated proven best practices, Emaginos opposes replacing public schools with charter schools or damaging public schools by draining resources through vouchers or school choice programs. Emaginos firmly believes in restoring the concept of the neighborhood schools as the center of the community. For more information about Emaginos and to learn about investment and shareholder opportunities, visit www.Emaginos.com. NOTE TO INVESTORS: The latest news and updates relating to Emaginos are available in the company’s newsroom at https://ibn.fm/Emaginos

• Natural farming is one of the solutions for mitigating the impacts of climate change, says article
• Simply Sonoma embodies the idea of organic farming in a way few other companies in the CBD space do
• From seed to sale, the company owns or contracts the organic grow, extraction and product formulation operations

A recent MJBizDaily article touts the importance of organic farming, noting that “as the legal marijuana industry continues to expand, it’s urgent that we understand the consequences of placing too much reliance on large industrial cannabis grown indoors under artificial lighting.” A different kind of natural company, Simply Sonoma embodies the idea of organic farming in a way few other companies in the CBD sector do. “Now is the imperative time to acknowledge natural farming as one of the solutions for mitigating the impacts of climate change,” the MJBizDaily article states (https://ibn.fm/fiAM0). “We should be looking for ways to be kinder to the Earth and to reject harmful chemical-intensive agricultural practices. We should embrace organic farming methods that improve soil health and build resilient, regenerative supply chains that nurture both people and planet.” The article goes on to indicate that recent research indicates that more than 53% of consumers are willing to pay more for organic cannabis products. With this in mind, Simply Sonoma appears to be perfectly positioned as an organic product company in every sense possible. From seed to sale, the company owns or contracts the organic grow, extraction and product formulation operations, ensuring the quality and sustainability of the entire process. The company has been developing products since 2017 based on scientific research and data, and is preparing to unveil several innovative, organic CBD products featuring Simply Sonoma’s proprietary formulations. Simply Sonoma is committed to building a reputation for being a leader in plant-based medicinal health and beauty products. As part of that commitment, the company is focused on developing broad-spectrum CBD products for therapeutic applications from a scientific perspective. Its products come from the farm rather than from a lab, with the goal of achieving fewer side effects and more efficacy for patients. The company believes in published, science-based trials and research when it comes to its CBD creations. Simply Sonoma also partners exclusively with organizations that share its focus; the company is committed to only collaborate with enterprises that are environmentally conscious, solar first and organic- equivalent. For example, the company works closely with Sonoma Biologics, a premium hemp cultivator that has completed considerable research on the scientific nature of hemp and cannabis, to grow and cultivate medicinal strains exclusively for Simply Sonoma. Simply Sonoma is also working with Organic Vineyards on the development of its game-changing antioxidant, alcohol-free, CBD wine product and its low-carb, low-sugar Pinot Noir CBD sparkling product. Simply Sonoma is a different kind of natural company and looks forward to introducing its exceptional products to the consumer market. For more information, or to invest in Simply Sonoma, visit the company’s website at www.SimplySonoma.org. NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma